from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3436c/glmS

LFCtreatmentdescriptionclass of inhibitor

-0.546

Amikacinug/mL Amikacintranslation

0.586

Cap5-10ug/mL Capreomycintranslation

0.593

Rox10-50 ug/mL Roxithromycintranslation

0.609

SM2-5 ug/mL Streptomycintranslation

0.257

Tet5-10 ug/mL Tetracyclinetranslation

0.277

Rif0.2-5ug/mL Rifampicintranscription

-0.379

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.347

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.753

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.524

CPZ10-50 ug/mL Chlorpromazinerespiration

1.633

Clofazimine10-13 ug/mL Clofaziminerespiration

0.358

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.764

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.038

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.701

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.874

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.279

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.769

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.586

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.215

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.480

KCN5-20 ug/mL Potassium cyaniderespiration

0.489

NaN30.2-2 mM Sodium aziderespiration

1.519

Nigericin50 uM Nigericinrespiration

-0.922

TRC10-150 ug/mL Triclosanrespiration

1.684

TRZ10-25 ug/mL Thioridazinerespiration

-0.021

Valinomycin0.5-10 uM Valinomycinrespiration

1.052

ZnSO42 mM ZnSO4respiration

0.574

menadione6-10 ug/mL Menadionerespiration

0.410

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.114

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.218

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.011

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.813

NRP_1Non-replicating persistence stage 1dosRassociated

-0.135

Amp0.2mg/mL AmpicillincellWall

-0.332

Cephalexin20-100 ug/mL CephalexincellWall

0.409

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.092

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.089

EMB10-20 ug/mL EthambutolcellWall

0.075

Eta12-40 ug/mL EthionamidecellWall

0.841

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.025

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.757

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.189

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.987

BZA0.12 mg/mL BenzamidearomaticAmides

-0.715

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.463

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.183

H2O24 mM hydrogen peroxideDNAdamaging

-0.568

Levo10 ug/mL LevofloxacinDNAdamaging

-0.184

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.191

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.093

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.149

UVUV-irradiationDNAdamaging

0.768

ARP41-4 ug/mL Antitubercular compound ARP4?

0.033

Antimycin12.5-50 ug/mL Antimycin A?

-0.049

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.449

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.184

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.433

PA8240.2-2 ug/mL PA-824?

-1.561

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.901

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.173

Verapamil50 uM Verapamil?

-0.139

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.004

methoxatin10-20 ug/mL Methoxatin?